ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,695,222 | -87.3% | 357,230 | -85.7% | 0.01% | -86.0% |
| Q2 2023 | $76,555,326 | -23.5% | 2,490,414 | -10.4% | 0.04% | -24.6% |
| Q1 2023 | $100,115,120 | +26.9% | 2,778,660 | +39.2% | 0.06% | +14.0% |
| Q4 2022 | $78,901,202 | -17.9% | 1,996,437 | -16.5% | 0.05% | -25.4% |
| Q3 2022 | $96,118,010 | +963.1% | 2,391,857 | +1012.7% | 0.07% | +1016.7% |
| Q2 2022 | $9,041,023 | +34.6% | 214,953 | +24.8% | 0.01% | +50.0% |
| Q1 2022 | $6,716,766 | +1522.4% | 172,238 | +1559.2% | 0.00% | – |
| Q4 2021 | $414,000 | +10.4% | 10,381 | 0.0% | 0.00% | – |
| Q3 2021 | $375,000 | -93.2% | 10,381 | -92.3% | 0.00% | -100.0% |
| Q2 2021 | $5,525,000 | -34.5% | 134,781 | -30.3% | 0.00% | -42.9% |
| Q1 2021 | $8,436,000 | -18.7% | 193,389 | -6.7% | 0.01% | -30.0% |
| Q4 2020 | $10,379,000 | +33.6% | 207,355 | +12.3% | 0.01% | +25.0% |
| Q3 2020 | $7,767,000 | -18.1% | 184,621 | -14.6% | 0.01% | -11.1% |
| Q2 2020 | $9,489,000 | – | 216,145 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |